Kenneth N. Keirstead
Gründer bei Lyceum Group
Profil
Kenneth N.
Keirstead is the founder and the Executive Manager of Lyceum Group, which was founded in 1998.
He also held the position of President & Chief Executive Officer at Sanofi Canada, Inc. Dr. Keirstead was the President & Chief Executive Officer of Sanofi Winthrop Canada, Inc. from 1989 to 1993.
He served as an Independent Director at Intellipharmaceutics International, Inc. and as a Director at Soricimed Biopharma, Inc. Dr. Keirstead was the President of Quinton Instrument Co. and the General Manager of Squibb Medical Systems International.
He obtained his undergraduate degree from The Trustees of Columbia University in The City of New York and The College of William & Mary.
Aktive Positionen von Kenneth N. Keirstead
| Unternehmen | Position | Beginn |
|---|---|---|
Lyceum Group
 Lyceum Group Miscellaneous Commercial ServicesCommercial Services Lyceum Group operates as a consulting services. It primarily active in the health care field. The company was founded by Kenneth Keirstead in 2000 and is headquartered in Frederictont, Canada. | Gründer | 01.01.1998 |
Ehemalige bekannte Positionen von Kenneth N. Keirstead
| Unternehmen | Position | Ende |
|---|---|---|
Soricimed Biopharma, Inc.
 Soricimed Biopharma, Inc. BiotechnologyHealth Technology Soricimed Biopharma, Inc. develops novel cancer therapeutics and diagnostics. Its programs include SOR-C13 and Peptide-Drug Conjugate. The company was founded by Jack Stewart and Paul Gunn in 2005 and is headquartered in Moncton, Canada. | Direktor/Vorstandsmitglied | 04.09.2018 |
| Sanofi Winthrop Canada, Inc. | Vorstandsvorsitzender | 01.07.1993 |
| Squibb Medical Systems International | Corporate Officer/Principal | - |
| Quinton Instrument Co. | Präsident | - |
Sanofi Canada, Inc.
 Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada. | Vorstandsvorsitzender | - |
Ausbildung von Kenneth N. Keirstead
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| The College of William & Mary | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INTELLIPHARMACEUTICS INTERNATIONAL INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Soricimed Biopharma, Inc.
Soricimed Biopharma, Inc. BiotechnologyHealth Technology Soricimed Biopharma, Inc. develops novel cancer therapeutics and diagnostics. Its programs include SOR-C13 and Peptide-Drug Conjugate. The company was founded by Jack Stewart and Paul Gunn in 2005 and is headquartered in Moncton, Canada. | Health Technology |
| Quinton Instrument Co. | |
Lyceum Group
Lyceum Group Miscellaneous Commercial ServicesCommercial Services Lyceum Group operates as a consulting services. It primarily active in the health care field. The company was founded by Kenneth Keirstead in 2000 and is headquartered in Frederictont, Canada. | Commercial Services |
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada. | Health Technology |
| Squibb Medical Systems International | |
| Sanofi Winthrop Canada, Inc. |